Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.
about
Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation.Mathematical Modeling of Streptococcus pneumoniae Colonization, Invasive Infection and Treatment.Personalized Computational Models as BiomarkersPerformance of objective functions and optimisation procedures for parameter estimation in system biology models.Logic Modeling in Quantitative Systems Pharmacology.JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2-Targeted Therapies.Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.Computational models for predicting drug responses in cancer research.Predicting ligand-dependent tumors from multi-dimensional signaling features.Actionable pathways: interactive discovery of therapeutic targets using signaling pathway models.High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes.Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporterFrom word models to executable models of signaling networks using automated assembly.A roadmap towards personalized immunology.Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers.[Mathematical modeling: an essential tool for the study of therapeutic targeting in solid tumors].New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-OncologyModels of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcomeComparative Network Reconstruction using mixed integer programming
P2860
Q37626301-43242F64-F189-4814-B009-2CC74FACDEACQ37675458-806C39F2-26DC-4CC8-958A-F6B319A3F194Q38598058-B6715BFD-699D-45E5-8B74-DA724BAA15A0Q38626560-5EB27A6A-63D6-49F7-A655-21A568F04114Q38691620-BE0D2D3C-8E02-40C3-946A-38EEA7CEED26Q38756230-03796F7F-EF56-4073-A34A-DD5DE8A0A18AQ38891078-7D9E9BCD-FDBE-4679-98DE-892F3034FF99Q38904995-4FDEC8C5-3F59-49B1-8F64-55B5FA5352F6Q41701603-1269460D-7976-451F-AA77-A6222FB9C7F8Q41723803-4107AAD2-80A8-4418-B3EA-5C94F2CFFD8BQ42117770-F71D0FF9-33FB-43F3-B67E-DCE11DCD2BDFQ42212236-CEF270BD-41FA-48F4-ABF4-86942FA6757FQ47596954-6EA7ED55-1F12-45AE-8B87-FAB7EED13960Q50104991-0DD842C4-B8A7-4791-A23D-43CE59F37287Q51646294-6BC10583-A6F1-4DBF-9184-E98C4A8F02EAQ52407643-C30F2754-B34D-4439-8FD1-CE76FEBEFBA9Q52666594-8780E47A-64C6-49BF-AF22-D6F96F23C6F3Q57818011-254AEC41-CEC6-471B-9C64-D01742B49014Q57837746-27D4655A-59C4-4857-BFD6-D5714D58EAD0Q58757854-C9AD016C-1126-425C-A335-6E28504759BC
P2860
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Signaling pathway models as bi ...... val of neuroblastoma patients.
@en
type
label
Signaling pathway models as bi ...... val of neuroblastoma patients.
@en
prefLabel
Signaling pathway models as bi ...... val of neuroblastoma patients.
@en
P2093
P2860
P50
P1433
P1476
Signaling pathway models as bi ...... val of neuroblastoma patients.
@en
P2093
Amaya Garcia Munoz
Daniel Dreidax
David R Croucher
Frank Westermann
Jordan F Hastings
Matthias Fischer
Ruth Pilkington
P2860
P356
10.1126/SCISIGNAL.AAB0990
P577
2015-12-22T00:00:00Z